The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001033855.3(DCLRE1C):c.25G>A (p.Ala9Thr)

CA376066110

958156 (ClinVar)

Gene: DCLRE1C
Condition: severe combined immunodeficiency due to DCLRE1C deficiency
Inheritance Mode: Autosomal recessive inheritance
UUID: f6696015-fb44-4ba5-a42e-a99d939bd088
Approved on: 2024-04-01
Published on: 2024-04-01

HGVS expressions

NM_001033855.3:c.25G>A
NM_001033855.3(DCLRE1C):c.25G>A (p.Ala9Thr)
NC_000010.11:g.14953986C>T
CM000672.2:g.14953986C>T
NC_000010.10:g.14995985C>T
CM000672.1:g.14995985C>T
NC_000010.9:g.15035991C>T
NG_007276.1:g.5110G>A
ENST00000378241.6:c.25G>A
ENST00000456122.2:c.25G>A
ENST00000489161.2:c.25G>A
ENST00000492201.6:c.25G>A
ENST00000697047.1:c.25G>A
ENST00000697070.1:c.25G>A
ENST00000697071.1:c.25G>A
ENST00000697072.1:c.25G>A
ENST00000697073.1:c.25G>A
ENST00000697074.1:c.25G>A
ENST00000697075.1:c.25G>A
ENST00000697076.1:c.25G>A
ENST00000697077.1:c.25G>A
ENST00000697078.1:c.25G>A
ENST00000697080.1:c.25G>A
ENST00000697081.1:c.25G>A
ENST00000697082.1:c.25G>A
ENST00000697083.1:c.25G>A
ENST00000697084.1:c.25G>A
ENST00000697085.1:c.25G>A
ENST00000697087.1:c.25G>A
ENST00000697088.1:c.25G>A
ENST00000697089.1:c.25G>A
ENST00000697091.1:n.86G>A
ENST00000378278.7:c.25G>A
ENST00000357717.6:c.-180G>A
ENST00000378241.5:c.-548G>A
ENST00000378246.6:c.-265G>A
ENST00000378249.5:c.-213G>A
ENST00000378254.5:c.-467G>A
ENST00000378255.5:c.-789G>A
ENST00000378258.5:c.-421G>A
ENST00000378278.6:c.25G>A
ENST00000378289.8:c.25G>A
ENST00000396817.6:c.-743G>A
ENST00000418843.5:c.-504G>A
ENST00000456122.1:c.-672G>A
NM_001033855.2:c.25G>A
NM_001033857.2:c.-421G>A
NM_001033858.2:c.-743G>A
NM_001289076.1:c.-180G>A
NM_001289077.1:c.-467G>A
NM_001289078.1:c.-213G>A
NM_001289079.1:c.-789G>A
NM_022487.3:c.-265G>A
NR_110297.1:n.447G>A
NM_001350965.1:c.25G>A
NM_001350966.1:c.-213G>A
NM_001350967.1:c.-421G>A
NR_146960.1:n.447G>A
NR_146961.1:n.447G>A
NR_146962.1:n.447G>A
NM_001033857.3:c.-421G>A
NM_001033858.3:c.-743G>A
NM_001289076.2:c.-180G>A
NM_001289077.2:c.-467G>A
NM_001289078.2:c.-213G>A
NM_001289079.2:c.-789G>A
NM_001350965.2:c.25G>A
NM_001350966.2:c.-213G>A
NM_001350967.2:c.-421G>A
NM_022487.4:c.-265G>A
NR_110297.2:n.111G>A
NR_146961.2:n.111G>A
More

Uncertain Significance

Met criteria codes 1
PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Severe Combined Immunodeficiency Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for DCLRE1C Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Severe Combined Immunodeficiency Disease VCEP
The c.25G>A (NM_001033855.3) variant in DCLRE1C is a missense variant predicted to cause the substitution of Alanine by Threonine at amino acid 9 (p.Ala9Thr). The highest population minor allele frequency in gnomAD v4 is 0.00003022 (1/33086 alleles) in the "Remaining" population, which is lower than the ClinGen SCID VCEP threshold (<0.00003266) for PM2_Supporting. Despite the "Remaining" being considered a bottleneck population in gnomad v4, as no other alleles have been described in all other populations, PM2_Supporting still can be applied (PM2_Supporting). Allele frequency considering all exomes is 0.000001591, 1/628590 alleles. To our knowledge, this variant has not been reported in the literature in individuals affected with DCLRE1c-related conditions or in functional studies. In summary, this variant is classified as a variant of uncertain significance for autosomal recessive severe combined immunodeficiency due to DCLRE1C deficiency, based on ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP (specification version 1.0): PM2_Supporting.
Met criteria codes
PM2_Supporting
The highest population minor allele frequency in gnomAD v4 is 0.00003022 (1/33086 alleles) in the "Remaining" population, which is lower than the ClinGen SCID VCEP threshold (<0.00003266) for PM2_Supporting. Despite the "Remaining" being considered as a bottleneck population in gnomad v4, as no other alleles have been described in all other populations, PM2_Supporting still can be applied (PM2_Supporting). Allele frequency considering all exomes is 0.000001591, 1/628590 alleles.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.